Biomaterials for vascular tissue engineering

Regenerative Medicine

Volumn 5, Issue 1, 2010, Pages 107-120

  Ravi, Swathi ^a,b   Chaikof, Elliot L ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Emory University   (United States)

^c Georgia Institute of Technology   (United States)

Author keywords

Biomaterials; Biopolymers; Degradable polymer scaffolds; Endothelialization; In situ vascular regeneration; Tissue engineering; Vascular grafts

Indexed keywords

BIOMATERIAL; DACRON; MACROGOL; NANOCOMPOSITE; POLITEF; POLYCAPROLACTONE; POLYGLACTIN; POLYHYDROXYALKANOIC ACID; POLYLACTIC ACID; POLYMER; POLYURETHAN; TISSUE SCAFFOLD;

ARTERY RECONSTRUCTION; BIODEGRADABILITY; BIOMECHANICS; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; DACRON VASCULAR PROSTHESIS; EQUIPMENT DESIGN; EXTRACELLULAR MATRIX; FEMOROPOPLITEAL BYPASS; GRAFT PATENCY; HUMAN; LUNG TRANSPLANTATION; MATERIAL COATING; NONHUMAN; POLITEF IMPLANT; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; THROMBOGENICITY; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; HUMANS; TISSUE ENGINEERING;

EID: 77649294639     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.77     Document Type: Review

References (162)

1. Berger PB, Alderman EL, Nadel A, Schaff HV; for the International Multicenter Aprotinin Graft Patency Experience (IMAGE) Investigators: Frequency of early occlusion and stenosis in a left internal mammary artery to left anterior descending artery bypass graft after surgery through a median sternotomy on conventional bypass: benchmark for minimally invasive direct coronary artery bypass. Circulation 100(23), 2353-2358 (1999).
2. McKee JA, Banik SSR, Boyer MJ et al.: Human arteries engineered in vitro. EMBO Rep. 4(6), 633-638 (2003).
3. Verma S, Szmitko PE, Weisel RD et al.: Should radial arteries be used routinely for coronary artery bypass grafting? Circulation 110(5), e40-e46 (2004).
4. Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM: Current status of prosthetic bypass grafts: a review. J. Biomed. Mater. Res. B Appl. Biomater. 74(1), 570-581 (2005).
5. Abbott WM, Megerman J, Hasson JE, L'Italien G, Warnock DF: Effect of compliance mismatch on vascular graft patency. J. Vasc. Surg. 5(2), 376-382 (1987).
6. Conte MS: The ideal small arterial substitute: a search for the Holy Grail? FASEB J. 12(1), 43-45 (1998).
7. Greisler HP: Interactions at the blood/ material interface. Ann. Vasc. Surg. 4(1), 98-103 (1990).
8. Wittemore AD, Kent KC, Donaldson MC, Couch NP, Mannick JA: What is the proper role of polytetrafluoroethylene grafts in infrainguinal reconstruction? J. Vasc. Surg. 10, 299-305 (1989).
9. Humphrey JD: Mechanics of the arterial wall: review and directions. Crit. Rev. Biomed. Eng. 23(1-2), 1-162 (1995).
10. Weinberg CB, Bell E: A blood vessel model constructed from collagen and cultured vascular cells. Science 231(4736), 397-400 (1986).
11. Johnson WC, Lee KK: A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J. Vasc. Surg. 32(2), 268-277 (2000).
12. Xue L, Greisler HP: Biomaterials in the development and future of vascular grafts. J. Vasc. Surg. 37(2), 472-480 (2003).
13. Clowes AW, Kirkman TR, Reidy MA: Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. Am. J. Pathol. 123(2), 220-230 (1986).
14. Goldman M, McCollum CN, Hawker RJ, Drolc Z, Slaney G: Dacron arterial grafts: the influence of porosity, velour, and maturity on thrombogenicity. Surgery 92(6), 947-952 (1982).
15. Allen BT, Mathias CJ, Sicard GA, Welch MJ, Clark RE: Platelet deposition on vascular grafts. The accuracy of in vivo quantitation and the significance of in vivo platelet reactivity. Ann. Surg. 203(3), 318-328 (1986).
16. Goldman M, Hall C, Dykes J, Hawker RJ, McCollum CN: Does 111indium-platelet deposition predict patency in prosthetic arterial grafts? Br. J. Surg. 70(10), 635-638 (1983).
17. Hamlin GW, Rajah SM, Crow MJ, Kester RC: Evaluation of the thrombogenic potential of three types of arterial graft studied in an artificial circulation. Br. J. Surg. 65(4), 272-276 (1978).
18. Shepard AD, Gelfand JA, Callow AD, O'Donnell TF Jr: Complement activation by synthetic vascular prostheses. J. Vasc. Surg. 1(6), 829-838 (1984).
19. Abbott W, Green R, Matsumoto T et al.: Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. J. Vasc. Surg. 25(1), 19-28 (1997).
20. Nakagawa Y, Ota K, Sato Y, Teraoka S, Agishi T: Clinical trial of new polyurethane vascular grafts for hemodialysis: compared with expanded polytetrafluoroethylene grafts. Artif. Organs 19(12), 1227-1232 (1995).
21. Seifalian AM, Salacinski HJ, Tiwari A, Edwards A, Bowald S, Hamilton G: In vivo biostability of a poly(carbonate-urea)urethane graft. Biomaterials 24(14), 2549-2557 (2003).
22. Kapfer X, Meichelboeck W, Groegler FM: Comparison of carbon-impregnated and standard ePTFE prostheses in extra-anatomical anterior tibial artery bypass: a prospective randomized multicenter study. Eur. J. Vasc. Endovasc. Surg. 32(2), 155-168 (2006).
23. Nishibe T, O'Donnel S, Pikoulis E et al.: Effects of fibronectin bonding on healing of high porosity expanded polytetrafluoroethylene grafts in pigs. J. Cardiovasc. Surg. (Torino) 42(5), 667-673 (2001).
24. Li C, Hill A, Imran M: In vitro and in vivo studies of ePTFE vascular grafts treated with P15 peptide. J. Biomater. Sci. Polym. Ed. 16(7), 875-891 (2005).
25. Krijgsman B, Seifalian AM, Salacinski HJ et al.: An assessment of covalent grafting of RGD peptides to the surface of a compliant poly(carbonate-urea)urethane vascular conduit versus conventional biological coatings: its role in enhancing cellular retention. Tissue. Eng. 8(4), 673-680 (2002).
26. Walluscheck KP, Steinhoff G, Kelm S, Haverich A: Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides. Eur. J. Vasc. Endovasc. Surg. 12(3), 321-330 (1996).
27. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Fröschl A, Zilla P: Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann. Thorac. Surg. 71(Suppl. 5), S327-S331 (2001).
28. Greisler HP, Klosak JJ, Dennis JW, Karesh SM, Ellinger J, Kim DU: Biomaterial pretreatment with ECGF to augment endothelial cell proliferation. J. Vasc. Surg. 5(2), 393-399 (1987).
29. Randone B, Cavallaro G, Polistena A et al.: Dual role of VEGF in pretreated experimental ePTFE arterial grafts. J. Surg. Res. 127(2), 70-79 (2005).
30. Gray JL, Kang SS, Zenni GC et al.: FGF-1 affixation stimulates ePTFE endothelialization without intimal hyperplasia. J. Surg. Res. 57(5), 596-612 (1994).
31. Greisler HP, Cziperle DJ, Kim DU et al.: Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery 112(2), 244-254; discussion 254-255 (1992).
32. Greisler HP, Gosselin C, Ren D et al.: Biointeractive polymers and tissue engineered blood vessels. Biomaterials 17(3), 329-336 (1996).
33. Clagett GP, Burkel WE, Sharefkin JB et al.: Platelet reactivity in vivo in dogs with arterial prostheses seeded with endothelial cells. Circulation 69(3), 632-639 (1984).
34. Gosselin C, Vorp DA, Warty V et al.: ePTFE coating with fibrin glue, FGF-1, and heparin: effect on retention of seeded endothelial cells. J. Surg. Res. 60(2), 327-332 (1996).
35. Herring MB, Dilley R, Jersild RA Jr, Boxer L, Gardner A, Glove J: Seeding arterial prostheses with vascular endothelium. The nature of the lining. Ann. Surg. 190(1), 84-90 (1979). (Pubitemid 9247325)
36. Hubbell JA, Massia SP, Desai NP, Drumheller PD: Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology (NY) 9(6), 568-572 (1991).
37. Seifalian AM, Tiwari A, Hamilton G, Salacinski HJ: Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif. Organs 26(4), 307-320 (2002).
38. Zilla P, Deutsch M, Meinhart J: Endothelial cell transplantation. Semin. Vasc. Surg. 12(1), 52-63 (1999).
39. Hedeman Joosten PP, Verhagen H, Heijnen-Snyder G et al.: Thrombogenesis of different cell types seeded on vascular grafts and studied under blood-flow conditions. J. Vasc. Surg. 28(6), 1094-1103 (1998).
40. Pearson JD: Endothelial cell function and thrombosis. Baillieres Best Pract. Res. Clin. Haematol. 12(3), 329-341 (1999).
41. Greisler HP, Wise D, Trantolo D et al.: Regulation of vascular graft healing by induction of tissue incorporation. In: Human Biomaterials Applications. Wise D (Ed.). Humana Press, Totowa, NJ, USA, 227 (1996).
42. Rotmans JI, Heyligers JM, Verhagen HJ et al.: In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 112(1), 12-18 (2005).
43. Reynolds MM, Hrabie JA, Oh BK et al.: Nitric oxide releasing polyurethanes with covalently linked diazeniumdiolated secondary amines. Biomacromolecules 7(3), 987-994 (2006).
44. Taite LJ, Yang P, Jun H-W, West JL: Nitric oxide-releasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. J. Biomed. Mater. Res. B Appl. Biomater. 84(1), 108-116 (2008).
45. Motlagh D, Allen J, Hoshi R, Yang J, Lui K, Ameer G: Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J. Biomed. Mater. Res. A 82A(4), 907-916 (2007). (Pubitemid 47312906)
46. Kim BS, Mooney DJ: Engineering smooth muscle tissue with a predefined structure. J. Biomed. Mater. Res. 41(2), 322-332 (1998).
47. Mooney DJ, Mazzoni CL, Breuer C et al.: Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials 17(2), 115-124 (1996).
48. Wake MC, Gupta PK, Mikos AG: Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplant. 5(4), 465-473 (1996).
49. Greisler HP, Schwarcz TH, Ellinger J, Kim DU: Dacron inhibition of arterial regenerative activities. J. Vasc. Surg. 3(5), 747-756 (1986).
50. Yu TJ, Chu CC: Bicomponent vascular grafts consisting of synthetic absorbable fibers. I. In vitro study. J. Biomed. Mater. Res. 27(10), 1329-1339 (1993).
51. Yu TJ, Ho DM, Chu CC: Bicomponent vascular grafts consisting of synthetic absorbable fibers: part II: in vivo healing response. J. Invest. Surg. 7(3), 195-211 (1994).
52. Mooney DJ, Organ G, Vacanti JP, Langer R: Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant. 3(2), 203-210 (1994).
53. Fidkowski CW, Kaazempur-Mofrad MR, Borenstein J, Vacanti JP, Langer R, Wang Y: Endothelialized microvasculature based on a biodegradable elastomer. Tissue. Eng. 11(1-2), 302-309 (2005).
54. Niklason LE, Gao J, Abbott WM et al.: Functional arteries grown in vitro. Science 284(5413), 489-493 (1999).
55. Shum-Tim D, Stock U, Hrkach J et al.: Tissue engineering of autologous aorta using a new biodegradable polymer. Ann. Thorac. Surg. 68(6), 2298-2304; discussion 2305 (1999).
56. Fu P, Sodian R, Lüders C et al.: Effects of basic fibroblast growth factor and transforming growth factor-b on maturation of human pediatric aortic cell culture for tissue engineering of cardiovascular structures. ASAIO J. 50(1), 9-14 (2004).
57. Shinoka T, Shum-Tim D,Ma PX et al.: Creation of viable pulmonary artery autografts through tissue engineering. J. Thorac. Cardiovasc. Surg. 115(3), 536-545; discussion 545-546 (1998).
58. Watanabe M, Shin'oka T, Tohyama S et al.: Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng. 7(4), 429-439 (2001).
59. Shin'oka T, Imai Y, Ikada Y: Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 344(7), 532-533 (2001).
60. Shin'oka T, Matsumura G, Hibino N et al.: Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J. Thorac. Cardiovasc. Surg. 129(6), 1330-1338 (2005).
61. Matsumura G, Ishihara Y, Miyagawa-Tomita S et al.: Evaluation of tissue-engineered vascular autografts. Tissue Eng. 12(11), 3075-3083 (2006).
62. Ennett AB, Kaigler D, Mooney DJ: Temporally regulated delivery of VEGF in vitro and in vivo. J. Biomed. Mater. Res. A 79(1), 176-184 (2006).
63. Guan J, Stankus JJ, Wagne WR: Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J. Control Release 120(1-2), 70-78 (2007).
64. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J: Molecular Biology of the Cell (3rd Edition). Anderson M, Granum S (Eds). Garland Publishing, NY, USA (1994).
65. Buttafoco L, Kolkmana G, Engbers-Buijtenhuijs P et al.: Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials 27(5), 724-734 (2006).
66. Ottani V, Raspanti M, Ruggeri A: Collagen structure and functional implications. Micron 32(3), 251-260 (2001).
67. Nicolas FL, Gagnieu CH: Denatured thiolated collagen. II. Cross-linking by oxidation. Biomaterials 18(11), 815-821 (1997).
68. Habermehl J, Skopinska J, Boccafoschi F et al.: Preparation of ready-to-use, stockable and reconstituted collagen. Macromol. Biosci. 5(9), 821-828 (2005).
69. Charulatha V, Rajaram A: Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials 24(5), 759-767 (2003).
70. Brinkman WT, Nagapudi K, Thomas BS, Chaikof EL: Photo-cross-linking of type I collagen gels in the presence of smooth muscle cells: mechanical properties, cell viability, and function. Biomacromolecules 4(4), 890-895 (2003).
71. Elbjeirami WM, Yonter EO, Starcher BC, West JL: Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity. J. Biomed. Mater. Res. A 66(3), 513-521 (2003).
72. Orban JM, Wilson LB, Kofroth JA, El-Kurdi MS, Maul TM, Vorp DA: Crosslinking of collagen gels by transglutaminase. J. Biomed. Mater. Res. A 68(4), 756-762 (2004).
73. Hirai J, Matsuda T: Self-organized, tubular hybrid vascular tissue composed of vascular cells and collagen for low-pressure-loaded venous system. Cell Transplant. 4(6), 597-608 (1995).
74. Nerem RM, Ensley AE: The tissue engineering of blood vessels and the heart. Am. J. Transplant. 4(Suppl. 6), 36-42 (2004).
75. Nerem RM, Seliktar D: Vascular tissue engineering. Annu. Rev. Biomed. Eng. 3, 225-243 (2001).
76. Baguneid M, Murray D, Salacinski HJ et al.: Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes. Biotechnol. Appl. Biochem. 39(Pt 2), 151-157 (2004).
77. L'Heureux N, Germain L, Labbé R, Auger FA: In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J. Vasc. Surg. 17(3), 499-509 (1993).
78. Seliktar D, Black RA, Vito RP, Nerem RM: Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann. Biomed. Eng. 28(4), 351-362 (2000).
79. Cummings CL, Gawlittaa D, Nerema RM, Stegemann JP: Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 25(17), 3699-3706 (2004).
80. Ye Q, Zünda G, Benedikta P et al.: Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 17(5), 587-591 (2000).
81. Clark RA: Fibrin glue for wound repair: facts and fancy. Thromb. Haemost. 90(6), 1003-1006 (2003).
82. Jockenhoevel S, Zund G, Hoerstrup SP et al.: Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 19(4), 424-430 (2001).
83. Long JL, Tranquillo RT: Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol. 22(4), 339-350 (2003).
84. Swartz DD, Russell JA, Andreadis ST: Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am. J. Physiol. Heart Circ. Physiol. 288(3), H1451-H1460 (2005).
85. Grassl ED, Oegema TR, Tranquillo RT: A fibrin-based arterial media equivalent. J. Biomed. Mater. Res. A 66(3), 550-561 (2003).
86. Patel A, Fine B, Sandig M, Mequanint K: Elastin biosynthesis: The missing link in tissue-engineered blood vessels. Cardiovasc. Res. 71(1), 40-49 (2006).
87. Lillie MA, Gosline JM: The viscoelastic basis for the tensile strength of elastin. Int. J. Biol. Macromol. 30(2), 119-127 (2002).
88. Silver FH, Horvath I, Foran DJ: Viscoelasticity of the vessel wall: the role of collagen and elastic fibers. Crit. Rev. Biomed. Eng. 29(3), 279-301 (2001).
89. Silver FH, Snowhill PB, Foran DJ: Mechanical behavior of vessel wall: a comparative study of aorta, vena cava, and carotid artery. Ann. Biomed. Eng. 31(7), 793-803 (2003).
90. Isenberg BC, Tranquillo RT: Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann. Biomed. Eng. 31(8), 937-949 (2003).
91. Ramamurthi A, Vesely I: Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials 26(9), 999-1010 (2005).
92. Stock UA, Wiederschain D, Kilroy SM et al.: Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures. J. Cell Biochem. 81(2), 220-228 (2001).
93. Daamen WF, Hafmans T, Veerkamp JH, van Kuppevelt TH: Comparison of five procedures for the purification of insoluble elastin. Biomaterials 22(14), 1997-2005 (2001).
94. Buijtenhuijs P, Buttafoco L, Poot AA et al.: Tissue engineering of blood vessels: characterization of smooth-muscle cells for culturing on collagen-and-elastin-based scaffolds. Biotechnol. Appl. Biochem. 39(Pt 2), 141-149 (2004).
95. Nagapudi K, Brinkmana WT, Thomasa BS et al.: Viscoelastic and mechanical behavior of recombinant protein elastomers. Biomaterials 26(23), 4695-4706 (2005).
96. Cappello J, Crissman J, Dorman M et al.: Genetic engineering of structural protein polymers. Biotechnol. Prog. 6(3), 198-202 (1990).
97. McGrath KP, Tirrell DA, Kawai M, Mason TL, Fournier MJ: Chemical and biosynthetic approaches to the production of novel polypeptide materials. Biotechnol. Prog. 6(3), 188-192 (1990).
98. Meyer DE, Chilkoti A: Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system. Biomacromolecules 3(2), 357-367 (2002).
99. Chang DK, Urry DK: Molecular dynamics calculations on relaxed and extended states of the polypentapeptide of elastin. Chem. Phys. Lett. 147(4), 395-400 (1988).
100. Petka WA, Harden JL, McGrath KP, Wirtz D, Tirrell DA: Reversible hydrogels from self-assembling artificial proteins. Science, 281(5375), 389-392 (1998).
101. Urry DW: Physical chemistry of biological free energy transduction as demonstrated by elastin protein-based polymers. J. Phys. Chem. B 101, 11007-11028 (1997).
102. Urry DW: Five axioms for the functional design of peptide-based polymers as molecular machines and materials: principles for macromolecular assembly. Biopolymers 47, 167-178 (1998).
103. Nagarsekar A, Crissman J, Crissman M, Ferrari F, Cappello J, Ghandehari H: Genetic engineering of stimuli-sensitive silkelastin-like protein block copolymers. Biomacromolecules 4(3), 602-607 (2003).
104. Kwon IK, Kidoaki S, Matsuda T: Electrospun nano-to microfiber fabrics made of biodegradable copolyesters: structural characteristics, mechanical properties and cell adhesion potential. Biomaterials 26(18), 3929-3939 (2005).
105. Li M, Mondrinos MJ, Gandhi MR, Ko FK, Weiss AS, Lelkes PI: Electrospun protein fibers as matrices for tissue engineering. Biomaterials 26(30), 5999-6008 (2005).
106. van Hest JC, Tirrell DA: Protein-based materials, toward a new level of structural control. Chem. Commun. (Camb.) 2001(19), 1897-1904 (2001).
107. Wright ER, McMillan RA, Cooper A et al.: Thermoplastic elastomer hydrogels via self-assembly of an elastin-mimetic triblock polypeptide. Adv. Funct. Mater. 12(2), 1-6 (2002).
108. Wright ER, Conticello VP: Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences. Adv. Drug Deliv. Rev. 54(8), 1057-1073 (2002).
109. Lee SJ, Yoo JJ, Lim GJ, Atala A, Stitzel J: In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application. J. Biomed. Mater. Res. A 83(4), 999-1008 (2007).
110. Stankus JJ, Soletti L, Fujimoto K, Hong Y, Vorp DA, Wagner WR: Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization. Biomaterials 28(17), 2738-2746 (2007).
111. Barnes CP, Sell SA, Boland ED, Simpson DG, Bowlin GL: Nanofiber technology: designing the next generation of tissue engineering scaffolds. Adv. Drug Deliv. Rev. 59(14), 1413-1433 (2007).
112. Pham QP, Sharma U, Mikos AG: Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue. Eng. 12(5), 1197-1211 (2006).
113. de Mel A, Bolvin C, Edirisinghe M, Hamilton G, Seifalian AM: Development of cardiovascular bypass grafts: endothelialization and applications of nanotechnology. Expert Rev. Cardiovasc. Ther. 6(9), 1259-1277 (2008).
114. Li D, Xia YN: Electrospinning of nanofibers: reinventing the wheel? Adv. Funct. Mater. 16(14), 1151-1170 (2004).
115. He W, He W, Yong T, Teo WE, Ma Z, Ramakrishna S: Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering. Tissue. Eng. 11(9-10), 1574-1588 (2005).
116. Kannan RY, Salacinski HJ, De Groot J et al.: The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite. Biomacromolecules 7(1), 215-223 (2006).
117. Kannan RY, Salacinski HJ, Sales KM, Butler PE, Seifalian AM: The endothelialization of polyhedral oligomeric silsesquioxane nanocomposites: an in vitro study. Cell Biochem. Biophys. 45(2), 129-136 (2006).
118. Endo M, Koyama S, Matsuda Y, Hayashi T, Kim Y-A: Thrombogenicity and blood coagulation of a microcatheter prepared from carbon nanotube-nylon-based composite. Nano Lett. 5(1), 101-105 (2005).
119. Meng J, Kong H, Xu HY, Song L, Wang CY, Xie SS: Improving the blood compatibility of polyurethane using carbon nanotubes as fillers and its implications to cardiovascular surgery. J. Biomed. Mater. Res. A 74(2), 208-214 (2005).
120. Kim JY, Khang D, Lee JE, Webster TJ: Decreased macrophage density on carbon nanotube patterns on polycarbonate urethane. J. Biomed. Mater. Res. A 88(2), 419-426 (2009).
121. Hurt RH, Monthioux M, Kane A: Toxicology of carbon nanomaterials: status, trends, and perspectives on the special issue. Carbon 44(6), 1028-1033 (2006).
122. Dahl SL, Koh J, Prabhakar V, Niklason LE: Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 12(6), 659-666 (2003).
123. Schmidt CE, Baier JM: Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21(22), 2215-2231 (2000).
124. Tamura N, Nakamura T, Terai H et al.: A new acellular vascular prosthesis as a scaffold for host tissue regeneration. Int. J. Artif. Organs 26(9), 783-792 (2003).
125. Uchimura E, Sawa Y, Taketani S et al.: Novel method of preparing acellular cardiovascular grafts by decellularization with poly(ethylene glycol). J. Biomed. Mater. Res. A 67(3), 834-837 (2003).
126. Courtman DW, Errett BF, Wilson GJ: The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. J. Biomed. Mater. Res. 55(4), 576-586 (2001).
127. Khor E: Methods for the treatment of collagenous tissues for bioprostheses. Biomaterials 18(2), 95-105 (1997).
128. Amiel GE, Komura M, Shapira O et al.: Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue. Eng. 12(8), 2355-2365 (2006).
129. Cho SW, Lim SH, Kim I-K et al.: Small-diameter blood vessels engineered with bone marrow-derived cells. Ann. Surg. 241(3), 506-515 (2005).
130. Conklin BS, Richter ER, Kreutziger KL, Zhong DS, Chena C: Development and evaluation of a novel decellularized vascular xenograft. Med. Eng. Phys. 24(3), 173-183 (2002).
131. Conklin BS, Wu H, Lin PH, Lumsden AB, Chen C: Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft. Artif. Organs 28(7), 668-675 (2004).
132. DiMuzio P, Fischer L, McIlhenny S et al.: Development of a tissue-engineered bypass graft seeded with stem cells. Vascular 14(6), 338-342 (2006).
133. Holdsworth RJ, Naidu S, Gervaz P, McCollum P: Glutaraldehyde-tanned bovine carotid artery graft for infrainguinal vascular reconstruction: 5-year follow-up. Eur. J. Vasc. Endovasc. Surg. 14(3), 208-211 (1997).
134. Kaushal S, Amiel GE, Guleserian KJ et al.: Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med. 7(9), 1035-1040 (2001).
135. McFetridge PS, Bodamyali T, Horrocks M, Chaudhuri JB: Endothelial and smooth muscle cell seeding onto processed ex vivo arterial scaffolds using 3D vascular bioreactors. ASAIO J. 50(6), 591-600 (2004).
136. Shimizu K, Ito A, Arinobe M et al.: Effective cell-seeding technique using magnetite nanoparticles and magnetic force onto decellularized blood vessels for vascular tissue engineering. J. Biosci. Bioeng. 103(5), 472-478 (2007).
137. Voytik-Harbin SL, Brightman AO, Kraine MR, Waisner B, Badylak SF: Identification of extractable growth factors from small intestinal submucosa. J. Cell Biochem. 67(4), 478-491 (1997).
138. Badylak SF, Record R, Lindberg K, Hodde J, Park K: Small intestinal submucosa: a substrate for in vitro cell growth. J. Biomater. Sci. Polym. Ed. 9(8), 863-878 (1998).
139. Huynh T, Abraham G, Murray J, Brockbank K, Hagen P-O, Sullivan S: Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat. Biotechnol. 17(11), 1083-1086 (1999).
140. Marshall SE, Tweedt SM, Greene CH et al.: An alternative to synthetic aortic grafts using jejunum. J. Invest. Surg. 13(6), 333-341 (2000).
141. Robotin-Johnson MC, Swanson P, Johnson D, Schuessler R, Cox J: An experimental model of small intestinal submucosa as a growing vascular graft. J. Thorac. Cardiovasc. Surg. 116(5), 805-811 (1998).
142. Campbell GR, Ryan GB: Origin of myofibroblasts in the avascular capsule around free-floating intraperitoneal blood clots. Pathology 15(3), 253-264 (1983).
143. Campbell JH, Efendy JL, Han C-L, Girjes AA, Campbell GR: Haemopoietic origin of myofibroblasts formed in the peritoneal cavity in response to a foreign body. J. Vasc. Res. 37(5), 364-371 (2000).
144. Campbell JH, Efendy JL, Campbell GR: Novel vascular graft grown within recipient's own peritoneal cavity. Circ. Res. 85(12), 1173-1178 (1999).
145. Chue WL, Campbell G, Caplice N et al.: Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts. J. Vasc. Surg. 39(4), 859-867 (2004).
146. Efendy JL, Campbell GR, Campbell JH: The effect of environmental cues on the differentiation of myofibroblasts in peritoneal granulation tissue. J. Pathol. 192(2), 257-262 (2000).
147. Chen CH, Tsai C-C, Chen W et al.: Novel living cell sheet harvest system composed of thermoreversible methylcellulose hydrogels. Biomacromolecules 7(3), 736-743 (2006).
148. Sekine H, Shimizu T, Yang J, Kobayashi E, Okano T: Pulsatile myocardial tubes fabricated with cell sheet engineering. Circulation 114(Suppl. 1), I87-I93 (2006).
149. Yang J, Yamatoa M, Shimizu T et al.: Reconstruction of functional tissues with cell sheet engineering. Biomaterials 28(34), 5033-5043 (2007). (Pubitemid 47488500)
150. L'Heureux N, Dusserre N, Konig G et al.: Human tissue-engineered blood vessels for adult arterial revascularization. Nat. Med. 12(3), 361-365 (2006).
151. Chan G, Mooney DJ: New materials for tissue engineering: towards greater control over the biological response. Trends Biotechnol. 26(7), 382-392 (2008).
152. Rizzi SC, Ehrbar M, Halstenberg S et al.: Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules 7(11), 3019-3029 (2006).
153. Doi K, Matsuda T: Enhanced vascularization in a microporous polyurethane graft impregnated with basic fibroblast growth factor and heparin. J. Biomed. Mater. Res. 34(3), 361-370 (1997).
154. Chen L, Yu H, Dai N, Tao SF, Gong WH: Dual cell seeding to improve cell retention on polytetrafluoroethylene grafts. Zhonghua Wai Ke Za Zhi 41(2), 143-145 (2003).
155. Bhattacharya V, McSweeney PA, Shi Q et al.: Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34+ bone marrow cells. Blood 95(2), 581-585 (2000).
156. Fields C, Cassano A, Makhoul RG et al.: Evaluation of electrostatically endothelial cell seeded expanded polytetrafluoroethylene grafts in a canine femoral artery model. J. Biomater. Appl. 17(2), 135-152 (2002).
157. Griese DP, Ehsan A, Melo LG et al.: Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108(21), 2710-2715 (2003).
158. Izhar U, Schwalb Herzl, Borman JB: Novel synthetic selectively degradable vascular prostheses: a preliminary implantation study. J. Surg. Res. 95(2), 152-160 (2001).
159. Iwai S, Sawa Y, Ichikawa H et al.: Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis. J. Thorac. Cardiovasc. Surg. 128(3), 472-479 (2004).
160. Pektok E, Nottelet B, Tille JC et al.: Degradation and healing characteristics of small-diameter poly(e-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 118(24), 2563-2570 (2008).
161. Hashi CK, Zhu Y, Yang G-Y et al.: Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc. Natl Acad. Sci. USA 104(29), 11915-11920 (2007).
162. Hoerstrup SP, Cummings Mrcs I, Lachat M et al.: Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 114(Suppl. 1), I159-I166 (2006).